Figure 2From: Plasma soluble vascular endothelial growth factor receptor-1 levels predict outcomes of pneumonia-related septic shock patients: a prospective observational studyMean plasma biomarker levels in patient subgroups. (a) Vascular endothelial growth factor (VEGF) and (b) soluble vascular endothelial growth factor receptor 1 (sVEGFR1) levels and (c) urokinase plasminogen activator (uPA) activity in patients with pneumonia without organ dysfunction (open bar), pneumonia-related septic shock survivors at day 28 (shaded bar), and non-survivors at day 28 (solid bar). Means and standard errors of the mean of plasma biomarker levels are shown. Significance was tested with the two-sided Mann-Whitney U test.Back to article page